This page contains a Flash digital edition of a book.
INFECTION CONTROL Ing. Alberto L. Gómez Copello – Gómez Copello y Asociados


Contamination control: can cGMP help?


This article looks at how the application of cGMP methodology in the hospital environment can improve infection control.


In the last century, the pharmaceutical industry has introduced several new quality standards. One was Quality Assurance, or QA: Quality was not a random result, but a part to be added to the product itself. Standard operation procedures; double


checking; and validation were three concepts that eventually evolved in the 70s into the Good Manufacturing Practices. cGMP refers to the Current Good


Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). cGMPs set out systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the cGMP regulations includes a need to establish strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. These regulations evolved into a way of


thinking about quality and how to build it into the product. A common phrase was ‘This is (or is not) GMP’, indicating that a particular object or procedure fell within (or outside) the GMP.


Applying cGMP methodology The greatest achievement of these new regulations was that they covered facilities design and maintenance, gowning, disinfection, preparation, operation and


Stepping in the same place where somebody has been walking with dirty shoes makes your shoes dirty.


IFHE DIGEST 2015


paperwork as part of the manufacturing process. This methodology can also be applied to the healthcare procedures. Standard Operation Practices (SOPs) has to be written and supervision has to ensure that they are followed in every case. For example, operating theatres are to be


classified according to ISO 14644-1 cleanliness levels; airflow patterns should be established in order to determine if the critical procedures are being done in an adequate environment. Cleanliness procedures are to be also


specified, as well as training of the cleaning personnel, approval procedures for the quality of the cleaning and sanitization products, as well as the expiration date of each container. Periodical testing for surface particle and microbiological cleanliness shall be performed in a standardised way. All surgical clothing should be


manufactured in suitable fabrics that are neither fibre or particle- shedding – designed to avoid particles from the surgical team being scattered into the room’s atmosphere. Cleaning and sterilisation of this clothing should also be specified and verified. Gowning procedure should also be standardized and, if


the clothing is to be used in contact with an infectious patient, clothing disposal and sanitisation also has to be specified. Preparation and distribution of specialised drugs, such as oncological products, enteral and parenteral nutrition solutions, as well as prescription drugs, also need to be planned and verified. Taking, for example, a parenteral nutrition


solution. The physician in charge needs to order the nutrients required for each patient, and the order is delivered to the pharmacist in charge of the hospital pharmacy. They analyse whether the order can be prepared, and develop the procedure to prepare the solutions. A protocol shall be issued, indicating the drugs and materials needed, as well as the preparation technique and


Alberto L. Gómez Copello Alberto L. Gómez Copello is a chemical engineer who


graduated from the University of Buenos Aires in 1975. He is a former department head of Industrial Engineering and Projects at Eli Lilly Argentina; a technical manager at Mino Covo and, since 1998, owner of Gómez Copello y Asociados, a firm that specialises in cleanroom and containment area projects.


He has addressed several lectures on cleanroom design, pharmaceutical projects and biosafety areas in Argentina, Uruguay and Paraguay.


67


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96